These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 796739)

  • 1. Effect of alternate-day steroids on renal transplant function. A controlled study.
    McDonald FD; Horensten ML; Mayor GB; Turcotte JG; Selezinka W; Schork MA
    Nephron; 1976; 17(6):415-29. PubMed ID: 796739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, controlled, prospective study of the effect of alternate-day prednisone on renal transplant function.
    McDonald FD; Horensten ML; Schork MA; Turcotte JG
    Proc Clin Dial Transplant Forum; 1972; 2():5-7. PubMed ID: 4619674
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of alternate day steroids and daily steroids in renal transplant recipients.
    Davisson NA; Westervelt FB; Bolton WK
    Proc Clin Dial Transplant Forum; 1980; 10():150-4. PubMed ID: 7050977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful immunosuppression of renal allograft recipients with alternate day steroid therapy.
    Burleson RL; Scruggs BF; Brennan A
    Clin Nephrol; 1978 Sep; 10(3):87-9. PubMed ID: 359210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
    Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term alternate day steroid therapy in renal transplantation. A controlled study.
    Dumler F; Levin NW; Szego G; Vulpetti AT; Preuss LE
    Transplantation; 1982 Aug; 34(2):78-82. PubMed ID: 6753268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid treatment for routine immunosuppression in cadaver renal transplantation. A survey of hospitals.
    Kumar P; Leech SH; Gonzalez FM; Kodlin D
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():90-2. PubMed ID: 386327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternate day prednisone treatment may increase kidney transplant rejection.
    Leb DE
    Proc Clin Dial Transplant Forum; 1979; 9():136-9. PubMed ID: 399501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prednisone dose spacing on plasma lipids.
    Galla JH; Curtis JJ; Woodford SY; Rees ED; Somes GW; Luke RG
    J Lab Clin Med; 1980 Jun; 95(6):801-7. PubMed ID: 6991620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prednisone used as treatment for rejection correlates with poor outcome.
    Toussaint RM; Callender CO; Dunston GM; Flores J; Walters CS; John D; Yeager C; Bond O; Thompson C; Gear JC
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1712-5. PubMed ID: 2652561
    [No Abstract]   [Full Text] [Related]  

  • 11. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
    Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal of steroids after cadaveric kidney allotransplantation on maintenance triple therapy.
    Frei D; Keusch G; Hugentobler M; Probst W; Uhlschmid G; Largiadèr F; Binswanger U
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1620-2. PubMed ID: 2652527
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
    Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunosuppressive conversion from cyclosporine A to azathioprine in renal transplant patients.
    Paraiso AR; Ona ET; Alano FA; Ramos CP; De Luna M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1627. PubMed ID: 2652530
    [No Abstract]   [Full Text] [Related]  

  • 16. Granulocyte function in recipients of renal transplant from live related donors and from cadavers.
    Golshan N; Barker CF; MacGregor RR
    J Infect Dis; 1980 Dec; 142(6):876-83. PubMed ID: 7007525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of recurrent early homograft rejection on subsequent patient and renal graft survival.
    Rai GS; Wilkinson R; Elliott RW; Uldall PR; Taylor RM
    Clin Nephrol; 1976 Sep; 6(3):375-8. PubMed ID: 791554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hypertension in a renal transplant population on alternate-day steroid therapy.
    Curtis JJ; Galla JH; Kotchen TA; Lucas B; McRoberts JW; Luke RG
    Clin Nephrol; 1976 Mar; 5(3):123-7. PubMed ID: 770034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prednisone withdrawal in HLA identical and one haplotype-matched live-related donor and cadaver renal transplant recipients.
    Hariharan S; Schroeder TJ; Weiskittel P; Alexander JW; First MR
    Kidney Int Suppl; 1993 Oct; 43():S30-5. PubMed ID: 8246366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirements for safe prednisone discontinuation in late renal transplantation in recipients immunosuppressed with cyclosporine.
    Lloveras J; Puig JM; Comerma I; Orfila A; Mir M; Masramón J; Aubia J
    Transplant Proc; 1990 Aug; 22(4):1693-4. PubMed ID: 2202127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.